Today’s Solutions: April 21, 2024

In a major win for threatened species and habitats, the Australian state of New South Wales (NSW) has recently taken under refuge a massive piece of the country’s outback by purchasing it from a private owner.

Called the Narriearra, the new national park covers an area of 1,534 sq km (392 sq miles) in an area in the far north-west of the state. Its acquisition by authorities marks the largest purchase of private land for conservation in NSW’s history.

The new national park extends across floodplains, wetlands and landscapes “currently not found anywhere in NSW national parks”, said Matt Kean, the state’s environment minister.

The property, which borders Queensland and lies to the east of the town of Tibooburra, was owned by the O’Connor family for about a century. It is home to more than 25 threatened animal species, including the grey grasswren, an endangered passerine bird endemic to the region.

Charities and conservation groups have also praised the decision. “This new National Park is an example of the ambitious action required to slow and reverse the biodiversity extinction crisis,” said Stuart Blanch from World Wildlife Fund (WWF) Australia.

Solutions News Source Print this article
More of Today's Solutions

3 simple ways to save an extra $250 per month

Everyone loves to save money, so here are three easy ways you can free up $250 in your budget per month. Cancel subscriptions you ...

Read More

APA, AAPI, APIDA or AANHPI? The history and significance of the “Asian Americ...

“The journey of a thousand miles begins with one step.” ― Lao Tzu By Arielle Tiangco Weeks ago, seated cross-legged on my couch, I ...

Read More

Playing video games benefit key regions of the brain

A recent study from Georgia State University found that sensorimotor decision-making skills were superior in regular video game players to those that didn’t play ...

Read More

Novel blood cancer treatment effective in three-fourths of trial patients

According to new findings from an ongoing Phase 1/2 clinical research trial, a novel investigational immunotherapy resulted in successful response rates for 73 percent ...

Read More